Buprenorphine: A Better Option for Opioid Use Disorder Treatment in Pregnancy Compared to Methadone.
Where this comes from
- Record sourced from PubMed, PMID 40355279.
- Also identified by DOI 10.3122/jabfm.2024.240349R0 and PMC identifier 12096386.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Buprenorphine, rather than methadone, should be considered the preferred first-line therapy for opioid use disorder in pregnancy due to its more favorable neonatal outcomes.<sup>1</sup>.
Medical subject headings
- Buprenorphine
- Methadone
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Pregnancy Complications
- Analgesics, Opioid
- Narcotic Antagonists